Follow
Ildefonso Espigado
Ildefonso Espigado
Universidad de Sevilla, Departamento de Medicina.
Verified email at us.es - Homepage
Title
Cited by
Cited by
Year
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
M Binks, JR Passweg, D Furst, P McSweeney, K Sullivan, C Besenthal, ...
Annals of the rheumatic diseases 60 (6), 577-584, 2001
3472001
Extended reports-Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: Procedure related mortality and impact on skin disease
M Binks, JR Passweg, D Furst, P McSweeney, K Sullivan, C Besenthal, ...
Annals of the Rheumatic Diseases 60 (6), 577-584, 2001
347*2001
Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial
F Moniche, A Gonzalez, JR Gonzalez-Marcos, M Carmona, P Pinero, ...
Stroke 43 (8), 2242-2244, 2012
2492012
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
JA Snowden, J Passweg, JJ Moore, S Milliken, P Cannell, J Van Laar, ...
The Journal of Rheumatology 31 (3), 482-488, 2004
2112004
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled …
M Aguilar-Guisado, I Espigado, A Martín-Peña, C Gudiol, ...
The Lancet Haematology 4 (12), e573-e583, 2017
1942017
The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from …
A Urbano-Ispizua, C Rozman, P Pimentel, C Solano, J de la Rubia, ...
Blood, The Journal of the American Society of Hematology 97 (2), 383-387, 2001
1562001
Comparable survival between HIV+ and HIV non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation
JL Díez-Martín, P Balsalobre, A Re, M Michieli, JM Ribera, C Canals, ...
Blood, The Journal of the American Society of Hematology 113 (23), 6011-6014, 2009
1462009
Risk factors and outcome of COVID-19 in patients with hematological malignancies
JL Piñana, R Martino, I García-García, R Parody, MD Morales, G Benzo, ...
Experimental Hematology & Oncology 9 (1), 1-16, 2020
1372020
Autologous stem-cell transplantation in patients with HIV-related lymphoma
P Balsalobre, JL Díez-Martín, A Re, M Michieli, JM Ribera, C Canals, ...
J Clin Oncol 27 (13), 2192-2198, 2009
1342009
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients
P Ljungman, R de la Camara, L Perez-Bercoff, M Abecasis, ...
Haematologica 96 (8), 1231-1235, 2011
1302011
Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors
J De La Rubia, C Arbona, F De Arriba, C Del Cañizo, S Brunet, C Zamora, ...
Transfusion 42 (1), 4-9, 2002
1172002
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia
JR Passweg, M Rabusin, M Musso, Y Beguin, S Cesaro, G Ehninger, ...
British journal of haematology 125 (6), 749-755, 2004
1082004
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
A Pérez-García, R De la Camara, J Roman-Gomez, A Jimenez-Velasco, ...
Blood, The Journal of the American Society of Hematology 110 (1), 461-467, 2007
1012007
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings
A Urbano-Ispizua, C Rozman, P Pimentel, C Solano, J de la Rubia, ...
Blood, The Journal of the American Society of Hematology 100 (2), 724-727, 2002
962002
Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study
M Aguilar‐Guisado, M Jiménez‐Jambrina, I Espigado, M Rovira, ...
Clinical transplantation 25 (6), E629-E638, 2011
922011
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
VE Gómez, V García-Gutiérrez, LL Corral, IG Cadenas, AP Martínez, ...
Bone Marrow Transplantation 55 (3), 641-648, 2020
802020
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multi-center survey study
V Escamilla Gomez, V García Gutiérrez, T Caballero-Velázquez, ...
Blood 130 (Supplement 1), 1983-1983, 2017
802017
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease
M Jurado, C Vallejo, JA Pérez-Simón, S Brunet, C Ferra, P Balsalobre, ...
Biology of Blood and Marrow Transplantation 13 (6), 701-706, 2007
782007
Donor age‐related differences in PBPC mobilization with rHuG–CSF
J De la Rubia, MA Díaz, A Verdeguer, MJ Pascual, C Arbona, R Arrieta, ...
Transfusion 41 (2), 201-205, 2001
782001
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study
M Jurado, C De La Mata, A Ruiz-García, E López-Fernández, O Espinosa, ...
Cytotherapy 19 (8), 927-936, 2017
752017
The system can't perform the operation now. Try again later.
Articles 1–20